Editorial: Impact of diabetes on long-term mortality after presentation with acute myocardial infarction

Journal of Cardiovascular Medicine

Volumn 12, Issue 6, 2011, Pages 387-389

  Gale, Chris P ^a,b   Thow, Jonathan ^c   Batin, Phillip D ^d   Hall, Alistair S ^e  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Department of Cardiology ^*  (United Kingdom)

^c YORK TEACHING HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d NATIONAL HEALTH SERVICE   (United Kingdom)

^e LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANTICOAGULANT THERAPY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIABETIC PATIENT; EDITORIAL; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; FEMALE; HEART INFARCTION; MALE; TIME;

DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; TIME FACTORS;

EID: 79955807043     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328346a710     Document Type: Editorial

References (26)

1. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Circulation 2007; 116:2634-2653. (Pubitemid 350182388)
2. Rogers WJ, Frederick PD, Stoehr E, Canto JG, Ornato JP, Gibson CM, et al. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 2008; 156:1026-1034.
3. Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA Jr, Granger CB, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007; 297:1892-1900. (Pubitemid 46707843)
4. Gandhi GY, Roger VL, Bailey KR, Palumbo PJ, Ransom JE, Leibson CL, et al. Temporal trends in prevalence of diabetes mellitus in a populationbased cohort of incident myocardial infarction and impact of diabetes on survival. Mayo Clin Proc 2006; 81:1034-1040. (Pubitemid 44175014)
5. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004; 164:982-988. (Pubitemid 38581518)
6. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359:2140-2144. (Pubitemid 34694020)
7. Norhammar AM, Ryden L, Malmberg K, et al. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999; 22:1827-1831. (Pubitemid 29521869)
8. Gale CP, Manda SO, Weston CF, Birkhead JS, Batin PD, Hall AS. Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database. Heart 2009; 95:221-227.
9. West RM, Cattle BA, Bouyssie M, Squire I, de Belder M, Fox KA, et al. Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and Wales. Eur Heart J 2010; 32:706-711.
10. Dunlay SM, Alexander KP, Melloni C, Kraschnewski JL, Liang L, Gibler WB, et al. Medical records and quality of care in acute coronary syndromes: results from CRUSADE. Arch Intern Med 2008; 168:1692-1698.
11. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339:229-234. (Pubitemid 28350165)
12. Evans JMM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ 2002; 324:939.
13. Mukamal KJ, Nesto RW, Cohen MC, Muller JE, Maclure M, Sherwood JB, et al. Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care 2001; 24:1422-1427. (Pubitemid 33716431)
14. Berger AK, Breall JA, Gersh BJ, Johnson AE, Oetgen WJ, Marciniak TA, et al. Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project). Am J Cardiol 2001; 87:272-277. (Pubitemid 32144865)
15. Svensson AM, Dellborg M, Abrahamsson P, Karlsson T, Herlitz J, Duval SJ, et al. The influence of a history of diabetes on treatment and outcome in acute myocardial infarction, during two time periods and in two different countries. Int J Cardiol 2007; 119:319-325. (Pubitemid 46921252)
16. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 1999; 281:1291-1297. (Pubitemid 29174480)
17. Cubbon RM, Wheatcroft SB, Grant PJ, Gale CP, Barth JH, Sapsford RJ, et al. Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur Heart J 2007; 28:540-545. (Pubitemid 47355504)
18. Norhammar A, Malmberg K, Ryden L, Tornvall P, Stenestrand U, Wallentin L. Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003; 24:838-844. (Pubitemid 36528563)
19. Dunlay SM, Witt BJ, Allison TG, Hayes SN, Weston SA, Koepsell E, et al. Barriers to participation in cardiac rehabilitation. Am Heart J 2009; 158:852-859.
20. Bramlage P, Messer C, Bitterlich N, Pohlmann C, Cuneo A, Stammwitz E, et al. The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart 2010; 96:604-609.
21. Nunes V, Nelder J, O'Flynn N, Calvert N, Kuntze S, Smithson H, et al. Clinical Guidelines and Evidence Review for Medicines Adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2009.
22. Horne R, Weinman J, Barber N, Elliot R, Morgan M. Concordance, adherence and compliance in medicine-taking. Report for the National Coordinating Centre for NHS Service Delivery and Organisation R&D; 2005.
23. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al. Intense metabolic control by means of insulin in patients with Diabetes Mellitus and Acute Myocardial Infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26:650-661. (Pubitemid 40516876)
24. Allen LA, O'Donnell CJ, Camargo CA Jr, Giugliano RP, Lloyd-Jones DM. Comparison of long-term mortality across the spectrum of acute coronary syndromes. Am Heart J 2006; 151:1065-1071.
25. Fox KA, Anderson FA Jr, Dabbous OH, Steg PG, Lopez-Sendon J, Van de Werf F, et al. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart 2007; 93:177-182. (Pubitemid 46180290)
26. Weston C, Walker L, Birkhead J. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome. Heart 2007; 93:1542-1546.-pii 012446652011060000 (Pubitemid 350205546)